Difference between revisions of "Part:BBa I0460:Experience"

 
(User Reviews)
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
 
 
__NOTOC__
 
__NOTOC__
 
This experience page is provided so that any user may enter their experience using this part.<BR>Please enter
 
This experience page is provided so that any user may enter their experience using this part.<BR>Please enter
Line 5: Line 4:
  
 
===Applications of BBa_I0460===
 
===Applications of BBa_I0460===
 +
 +
This part is used as a inactivator of AHL.
  
 
===User Reviews===
 
===User Reviews===
 
<!-- DON'T DELETE --><partinfo>BBa_I0460 StartReviews</partinfo>
 
<!-- DON'T DELETE --><partinfo>BBa_I0460 StartReviews</partinfo>
<!-- Template for a user review
+
<!-- Template for a user review -->
 
{|width='80%' style='border:1px solid gray'
 
{|width='80%' style='border:1px solid gray'
 
|-
 
|-
 
|width='10%'|
 
|width='10%'|
 
<partinfo>BBa_I0460 AddReview number</partinfo>
 
<partinfo>BBa_I0460 AddReview number</partinfo>
<I>Username</I>
+
<I>Youri</I>
 
|width='60%' valign='top'|
 
|width='60%' valign='top'|
Enter the review inofrmation here.
+
 
 +
This part was tested as a subpart in [https://parts.igem.org/Part:BBa_K546001 K546001] and found to be functional for inactivation of [https://parts.igem.org/3OC6HSL 3-oxohexanoyl-homoserine lactone].
 +
 
 +
<I>Team Wageningen UR 2011</I>
 
|};
 
|};
 
<!-- End of the user review template -->
 
<!-- End of the user review template -->
 
<!-- DON'T DELETE --><partinfo>BBa_I0460 EndReviews</partinfo>
 
<!-- DON'T DELETE --><partinfo>BBa_I0460 EndReviews</partinfo>

Latest revision as of 13:51, 21 September 2011

This experience page is provided so that any user may enter their experience using this part.
Please enter how you used this part and how it worked out.

Applications of BBa_I0460

This part is used as a inactivator of AHL.

User Reviews

UNIQb7faed20aa103ef8-partinfo-00000000-QINU

No review score entered. Youri

This part was tested as a subpart in K546001 and found to be functional for inactivation of 3-oxohexanoyl-homoserine lactone.

Team Wageningen UR 2011

;

UNIQb7faed20aa103ef8-partinfo-00000002-QINU